ClinicalTrials.gg
RecruitingNCT07614555Updated Jun 1, 2026

Flow-Controlled Versus Volume-Controlled Ventilation in Lumbar Disc Herniation Surgery

An interventional study of FCV Group and VCV Group in Lumbar Disc Herniation Surgery and Mechanical Ventilation, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 121 studies in Intervertebral Disc Displacement with a site in Turkey — 22 open to participants now, 28 under way, none of them phase 3. Intervertebral Disc Displacement · Turkey.

Planned enrollment
24th of 86
80 · median 60
Started
2026
with 11 others
No phase
85 of 121
11 open now
Primary completion
2026-11
later than 21 of 27 live
Registered
111th of 121
by date

Among the 121 studies in Intervertebral Disc Displacement with a site in Turkey, this one is the 24th largest by planned enrollment of the 86 interventional ones that give a count, is one of 12 that started in 2026, is one of 85 with no phase, reaches primary completion later than 21 of the 27 other live ones, and was the 111th registered.

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.

Browse Intervertebral Disc Displacement studies →

Open to participants now

22 of the 121 studies in Intervertebral Disc Displacement with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 121 studies in Intervertebral Disc Displacement with a site in Turkey, or all of them as a file.
02

Study summary

This prospective randomized trial aims to compare the effects of flow-controlled ventilation (FCV) and volume-controlled ventilation (VCV) on intraoperative airway pressures and oxygenation in patients undergoing lumbar disc herniation surgery under general anesthesia.

Adult patients aged 18-65 years, with ASA physical status I-III and a body mass index of 18-30 kg/m², will be allocated to receive either FCV or VCV during routine intraoperative mechanical ventilation. Ventilatory parameters, including peak airway pressure, plateau pressure, pulmonary compliance, EtCO₂, SpO₂, and arterial blood gas variables, will be recorded at predefined time points after intubation.

The primary endpoint is the PaO₂ value measured after 20 minutes in the prone position.

By comparing respiratory mechanics and oxygenation between the two ventilation modes, this study aims to contribute to the optimization of intraoperative ventilatory management in lumbar disc herniation surgery.

03

Conditions studied

  • Lumbar Disc Herniation Surgery
  • Mechanical Ventilation

Keywords

  • Flow-Controlled Ventilation
  • Volume-Controlled Ventilation
  • Lumbar Disc Herniation Surgery
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years
  • I-III
  • between 18 and 30 kg/m²

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years or > 65 years
  • Known or previously diagnosed pulmonary disease
  • Patients with severe preoperative pulmonary function impairment (e.g., \< 50% predicted, severe restrictive or obstructive pathology)
  • Patients with markedly altered lung anatomy or function due to prior major thoracic surgery
  • Patients who were dependent on supplemental oxygen therapy in the preoperative period
  • IV or higher
  • Refusal or inability to provide
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    FCV Group

    Patients allocated to the FCV group will receive intraoperative mechanical ventilation using a flow-controlled ventilation mode during surgery under general anesthesia. %50 FiO₂ will be applied, and a driving pressure of 12 cmH₂O will be used. After intubation, the patient will be placed in the prone position. Following the prone position, the patient's FiO₂ will be maintained between 0.8 and 1.0 for 20 minutes. After the 20th minute, ventilator settings will be returned to the baseline values. Tidal volume will be generated and recorded by the ventilator according to the driving pressure and the patient's lung mechanics. Minute ventilation will be adjusted based on the target tidal volume. The target tidal volume will be set at 6-8 mL/kg (7 mL/kg) with a respiratory rate of 12 breaths/min. Positive end-expiratory pressure (PEEP) will be maintained at 5 cmH₂O. The respiratory rate will be further titrated to maintain ETCO₂ between 35 and 40 mmHg.

    Procedure: FCV Group

  • Active comparator
    VCV Group

    Patients allocated to the VCV group will receive intraoperative mechanical ventilation using a conventional volume-controlled ventilation mode throughout surgery under general anesthesia. Anesthetic induction, monitoring, and perioperative management will follow the same standardized clinical protocols as those used in the FCV group. Ventilatory parameters, including peak and plateau airway pressures and arterial blood gas measurements, will be collected at identical predefined intraoperative time points. This group serves as the comparator arm for evaluating the effects of volume-controlled ventilation on airway pressures and oxygenation in these patients.

    Procedure: VCV Group

Interventions

  • ProcedureFCV Group

    Patients allocated to the FCV group will receive intraoperative mechanical ventilation using a flow-controlled ventilation mode during surgery under general anesthesia. Patients will be started on ventilation after intubation with 50% oxygen, driving pressure 12, PEEP 5, and a 1:1 inspiration/expiratory ratio.

  • ProcedureVCV Group

    Patients allocated to the VCV group will receive intraoperative mechanical ventilation using a conventional volume-controlled ventilation mode throughout surgery under general anesthesia. Patients will be started on ventilation after intubation with 50% oxygen, 7 ml/ideal body weight tidal volume, PEEP 5, 12 breaths per minute frequency, and a 1:2 inspiration/expiration ratio.

06

What researchers measure

Primary outcomes

  1. The PaO₂ measured 20 minutes after prone position.

    The primary outcome measure will be the PaO₂ derived from arterial blood gas analysis at 20 minutes after the prone position.

    Time frame: 20 minutes after the prone position, in the intraoperative period.

Secondary outcomes

  1. The PaO₂ measured during perioperative period

    The PaO₂ values will be measured and recorded using arterial blood gas analysis.

    Time frame: Day 1

  2. Peak airway pressure (Ppeak) values during perioperative period

    Ppeak will be measured and recorded.

    Time frame: Day 1

  3. Plateau airway pressure (Pplateau) values during perioperative period

    Pplateau will be measured and recorded.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.

Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 5 months is below that.

Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
May 18, 2026
First posted
May 29, 2026
StartActual
May 28, 2026
Primary completionEst.
Nov 12, 2026
CompletionEst.
Nov 26, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07614555
Responsible party
Atakan Sezgi (Principal Investigator, Ankara Etlik City Hospital) — Principal investigator
First posted
May 29, 2026
Start date
May 28, 2026
Primary completion
Nov 12, 2026 (estimated)
Completion
Nov 26, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Atakan Sezgi
Contact
kansezgi@gmail.com
00905323327000
Musa Zengin
Contact
musazengin@gmail.com
00905307716235

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion